Panitumumab (powder)
Panitumumab (ABX-EGF) (powder) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab (powder) inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab (powder) can be used in the research of cancers, such as colon cancer[1].
Product Specifications
CAS Number
339177-26-3
Product Name Alternative
ABX-EGF (powder)
UNSPSC
12352203
Target
EGFR
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
[Panitumumab(powder)]
Molecular Weight
(144.32 kDa)
References & Citations
[1]Liu SH, et al. EGFR monoclonal antibody panitumumab inhibits chronic proliferative cholangitis by downregulating EGFR. Int J Mol Med. 2019 Jul;44 (1) :79-88.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15300545 1 Vial
Lentiviral human ITGB4 shRNA (UAS) - Lentiviral human ITGB4 shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details 
124429-ML650 100 µL
CCDC5 (HAUS Augmin-like Complex Subunit 1, Coiled-coil Domain-containing Protein 5, Enhancer Of Invasion-Cluster, HEI-C, HAUS1, HEIC, FLJ21094, FLJ40084) (MaxLight 650)
Sign In for Pricing
View Details 
101801F0-AAT 25 Tests
APC/iFluor® 700 Anti-human CD18 Antibody *HI18a*
Sign In for Pricing
View Details